High-dose homoharringtonine versus standard-dose daunorubicin is effective and safe as induction and post-induction chemotherapy for elderly patients with acute myeloid leukemia: a multicenter experience from China.
| Image |  |
|---|---|
| Description | scientific article published on 22 January 2011 |
| Author/s |
author: Qing-Chun Zeng |
| Publication date | January 22, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |